No Data
Institutional Investors Own a Significant Stake of 34% in Sight Sciences, Inc. (NASDAQ:SGHT)
Lake Street Maintains Sight Sciences(SGHT.US) With Buy Rating, Maintains Target Price $10
Analysts Are Bullish on These Healthcare Stocks: Bioventus (BVS), Sight Sciences (SGHT)
Morgan Stanley Maintains Sight Sciences(SGHT.US) With Hold Rating, Raises Target Price to $7
Morgan Stanley analyst Kallum Titchmarsh maintains $Sight Sciences(SGHT.US)$ with a hold rating, and adjusts the target price from $5 to $7.According to TipRanks data, the analyst has a success rate
Sight Sciences: A Balanced View Amidst Recovery and Uncertainties
Lake Street Initiates Sight Sciences(SGHT.US) With Buy Rating, Announces Target Price $10
Lake Street analyst Frank Takkinen initiates coverage on $Sight Sciences(SGHT.US)$ with a buy rating, and sets the target price at $10.According to TipRanks data, the analyst has a success rate of 41.